Logo image of LRHC

LA ROSA HOLDINGS CORP (LRHC) Stock Fundamental Analysis

USA - NASDAQ:LRHC - US50172T2024 - Common Stock

5.68 USD
-0.42 (-6.89%)
Last: 10/20/2025, 8:00:08 PM
6.78 USD
+1.1 (+19.37%)
Pre-Market: 10/21/2025, 6:17:24 AM
Fundamental Rating

2

LRHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. LRHC may be in some trouble as it scores bad on both profitability and health. LRHC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LRHC has reported negative net income.
In the past year LRHC has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: LRHC reported negative net income in multiple years.
LRHC had negative operating cash flow in 4 of the past 5 years.
LRHC Yearly Net Income VS EBIT VS OCF VS FCFLRHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

LRHC has a Return On Assets of -115.01%. This is amonst the worse of the industry: LRHC underperforms 90.63% of its industry peers.
The Return On Equity of LRHC (-768.58%) is worse than 84.38% of its industry peers.
Industry RankSector Rank
ROA -115.01%
ROE -768.58%
ROIC N/A
ROA(3y)-68.89%
ROA(5y)-38.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LRHC Yearly ROA, ROE, ROICLRHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

With a Gross Margin value of 8.45%, LRHC is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
LRHC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LRHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.07%
GM growth 5YN/A
LRHC Yearly Profit, Operating, Gross MarginsLRHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

LRHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LRHC has more shares outstanding
The debt/assets ratio for LRHC is higher compared to a year ago.
LRHC Yearly Shares OutstandingLRHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
LRHC Yearly Total Debt VS Total AssetsLRHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

LRHC has an Altman-Z score of -0.43. This is a bad value and indicates that LRHC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LRHC (-0.43) is worse than 78.13% of its industry peers.
LRHC has a Debt/Equity ratio of 2.54. This is a high value indicating a heavy dependency on external financing.
LRHC's Debt to Equity ratio of 2.54 is on the low side compared to the rest of the industry. LRHC is outperformed by 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -0.43
ROIC/WACCN/A
WACC10.02%
LRHC Yearly LT Debt VS Equity VS FCFLRHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 2.12 indicates that LRHC has no problem at all paying its short term obligations.
LRHC has a better Current ratio (2.12) than 62.50% of its industry peers.
LRHC has a Quick Ratio of 2.12. This indicates that LRHC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LRHC (2.12) is better than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.12
LRHC Yearly Current Assets VS Current LiabilitesLRHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for LRHC have decreased strongly by -381.29% in the last year.
The Revenue has grown by 54.92% in the past year. This is a very strong growth!
The Revenue has been growing by 34.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-381.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.21%
Revenue 1Y (TTM)54.92%
Revenue growth 3Y34.1%
Revenue growth 5YN/A
Sales Q2Q%21.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LRHC Yearly Revenue VS EstimatesLRHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LRHC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LRHC Price Earnings VS Forward Price EarningsLRHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LRHC Per share dataLRHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300 -400

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LRHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LA ROSA HOLDINGS CORP

NASDAQ:LRHC (10/20/2025, 8:00:08 PM)

Premarket: 6.78 +1.1 (+19.37%)

5.68

-0.42 (-6.89%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.85%
Inst Owner Change0%
Ins Owners27.38%
Ins Owner Change343.57%
Market Cap6.93M
AnalystsN/A
Price TargetN/A
Short Float %3.76%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 2.02
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-482.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.36
FCFYN/A
OCF(TTM)-5.36
OCFYN/A
SpS63.96
BVpS2.81
TBVpS-8.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -115.01%
ROE -768.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.45%
FCFM N/A
ROA(3y)-68.89%
ROA(5y)-38.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.07%
GM growth 5YN/A
F-Score3
Asset Turnover3.41
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 2.12
Altman-Z -0.43
F-Score3
WACC10.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%222.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.92%
Revenue growth 3Y34.1%
Revenue growth 5YN/A
Sales Q2Q%21.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-357.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-357.27%
OCF growth 3YN/A
OCF growth 5YN/A